NIH #1R01CA289885-01A1
Leveraging First Mouse Model Reproducing Human Translocation Renal Cell Carcinoma to Investigate Molecular Mechanisms
Active
- Amount
- $597K
- Period
- 2026-06-20 → 2031-05-31
- PIs
- 1
- Est. capacity / PI
- ~9 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5P50CA196516-09
Core A: Administrative Core
Active
- Amount
- $260K
- Period
- 2016-08-01 → 2027-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5P50CA196516-08
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
Active
- Amount
- $2.2M
- Period
- 2016-08-01 → 2027-07-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5P50CA196516-07
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
Active
- Amount
- $2.2M
- Period
- 2016-08-01 → 2027-07-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #2P50CA196516-06A1
Core A: Administrative Core
Active
- Amount
- $153K
- Period
- 2016-08-01 → 2027-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R21CA263264-02
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
- Amount
- $225K
- Period
- 2021-07-02 → 2023-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #1R21CA263264-01
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
- Amount
- $192K
- Period
- 2021-07-02 → 2023-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5P50CA196516-05
Core A: Administrative Core
- Amount
- $178K
- Period
- 2016-08-01 → 2022-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5P50CA196516-03
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
- Amount
- $2.3M
- Period
- 2016-08-01 → 2021-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5P50CA196516-02
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
- Amount
- $2.3M
- Period
- 2016-08-01 → 2021-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #1P50CA196516-01A1
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
- Amount
- $2.2M
- Period
- 2016-08-01 → 2021-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA175754-05
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
- Amount
- $330K
- Period
- 2013-12-03 → 2019-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA175754-04
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
- Amount
- $330K
- Period
- 2013-12-03 → 2018-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA175754-03
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
- Amount
- $330K
- Period
- 2013-12-03 → 2018-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA175754-02
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
- Amount
- $330K
- Period
- 2013-12-03 → 2018-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #1R01CA175754-01A1
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
- Amount
- $330K
- Period
- 2013-12-03 → 2018-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA129387-05
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
- Amount
- $316K
- Period
- 2008-09-22 → 2014-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA129387-04
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
- Amount
- $316K
- Period
- 2008-09-22 → 2013-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA129387-03
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
- Amount
- $326K
- Period
- 2008-09-22 → 2013-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5R01CA129387-02
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
- Amount
- $326K
- Period
- 2008-09-22 → 2013-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5K08NS051843-05
VEGF regulation by the TSC2 tumor suppressor
- Amount
- $173K
- Period
- 2005-05-18 → 2010-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5K08NS051843-04
VEGF regulation by the TSC2 tumor suppressor
- Amount
- $173K
- Period
- 2005-05-18 → 2010-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #5P50CA196516-04
Project 1: Targeting HIF-2 for the Treatment of Clear-Cell Renal Cell Carcinoma
- Amount
- $296K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~4 students
Awarded at UT SOUTHWESTERN MEDICAL CENTER